Langenfeld, Germany

Franz Pirro

USPTO Granted Patents = 7 



Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1997-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Franz Pirro: Innovator in Veterinary Medicine

Introduction

Franz Pirro is a notable inventor based in Langenfeld, Germany. He has made significant contributions to the field of veterinary medicine, particularly through his innovative use of quinolone antibiotics. With a total of 7 patents to his name, Pirro's work has had a lasting impact on the treatment of bacterial disorders.

Latest Patents

One of his latest patents focuses on the use of certain quinolone antibiotics for controlling bacterial disorders of the oral cavity, specifically in veterinary medicine. This invention addresses a critical need in the field, providing effective solutions for animal health. Another notable patent involves novel optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives. This invention showcases his commitment to advancing pharmaceutical applications in veterinary care.

Career Highlights

Throughout his career, Franz Pirro has worked with prominent companies such as Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of veterinary medicine.

Collaborations

Franz Pirro has collaborated with notable colleagues, including Thomas Himmler and Thomas Jaetsch. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Franz Pirro's contributions to veterinary medicine through his innovative patents highlight his dedication to improving animal health. His work continues to influence the field, making him a significant figure in the realm of veterinary pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…